Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Diagnostic Prediction Model for de Novo Metastatic Breast Cancer Using Routinely Available Baseline Parameters

NCT07752238 is registered in ClinicalTrials.gov with Markusovszky University Teaching Hospital os County Vas as lead sponsor.

NCT NCT07752238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07752238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Diagnostic Prediction Model for de Novo Metastatic Breast Cancer Using Routinely Available Baseline Parameters
Lead sponsor
Markusovszky University Teaching Hospital os County Vas
Phase
Observational
Overall status
Recruiting
Start date
August 10, 2026
Completion date
February 28, 2027
Enrollment
925 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic invasive breast cancer